Farzian Aminuddin

Senior Director, Business Development at Ankyra

Farzian Aminuddin has a diverse work experience in the biotech and healthcare industry. Farzian'smost recent position was as Business Development Lead at Ankyra Therapeutics, a biotech company based in Cambridge. In this role, they focused on the development of anchored immunotherapeutic drugs for oncology, using the company's Anchored Immunotherapy Platform.

Prior to that, Farzian held various business development roles at Virogin Biotech, starting as a Senior Manager and later being promoted to Director. Farzian also worked as a Manager of Business Development at the Centre for Drug Research & Development, now known as adMare BioInnovations.

Before their business development roles, Farzian served as Manager of the Capital Access Advisory Program at the Ontario Bioscience Innovation Organization. Farzian also worked as a Business Analyst at Ontario Genomics and as a Business Consultant at the Provincial Health Services Authority.

Earlier in their career, Farzian worked as a Consultant at Innoguidance Consulting and as a Laboratory Researcher at the Institute for Heart + Lung Health.

Overall, Farzian Aminuddin has gained extensive experience in business development and research within the biotech and healthcare sectors.

Farzian Aminuddin's education history is as follows. From 2004 to 2009, they attended The University of British Columbia and obtained a Bachelor of Science (BSc) degree in Science. In 2005 to 2007, they studied at the British Columbia Institute of Technology and obtained a Diploma of Technology (DiT) in Biotechnology. In 2010 to 2011, they pursued a Graduate Diploma of Business Administration (GDBA) at Simon Fraser University. From 2011 to 2012, they attended the Beedie School of Business at Simon Fraser University and obtained a Master of Business Administration (MBA) degree. In 2014 to 2015, they studied at the University of Toronto and completed a Certificate in Business Innovation.

Links

Previous companies

PHSA logo

Peers

View in org chart

Timeline

  • Senior Director, Business Development

    January 1, 2024 - present

  • Business Development Lead

    April, 2023